Watanabe A, Kamata M, Okada Y, Suzuki S, et al. Clinical Outcomes of Tralokinumab and Lebrikizumab in Japanese Atopic Dermatitis Patients With Persistent Head and Neck Dermatitis After Long-Term Treatment With Dupilumab: A Single-Center Retrospective Study. J Dermatol 2025 Oct 16. doi: 10.1111/1346-8138.70026.
PMID: 41099301